Maine Physician Assistant Banned from Prescribing Drugs
Published Date: 3/20/2025
Notice
Summary
Rachel Jackson, a medical professional from Maine, lost her DEA registration because she no longer has the state authority to handle controlled substances. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration, which expired at the end of 2024. This means she can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
4 provisions identified: 0 benefits, 4 costs, 0 mixed.
No State License = No DEA Registration
If a practitioner is not authorized by their State to handle controlled substances, they are not eligible to keep a DEA registration. The DEA applied this rule here after finding Rachel Jackson voluntarily surrendered her Maine physician assistant license effective July 11, 2023.
Not Requesting a Hearing Risks Default
If a registrant does not file a written request for a hearing after receiving an Order to Show Cause, they are deemed in default and the factual allegations are admitted. The DEA may then seek final agency action and enter a default final order.
Order Revokes MG5136723; Denies Renewals
The DEA revoked Rachel Jackson's Certificate of Registration No. MG5136723 and denied any pending applications to renew, modify, or obtain additional registration in Maine. The Order is effective April 21, 2025.
DEA Can Proceed Even If Registration Expired
The DEA retains authority to adjudicate an Order to Show Cause even if a registrant's DEA registration expired during the proceeding. In this case, the Agency noted the registration expired on December 31, 2024 but continued to final action.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20749, Vladimir Romaniv, P.A.; Decision and Order
The DEA has officially suspended and is moving to revoke Vladimir Romaniv, P.A.'s registration because he gave multiple prescriptions without properly checking on a patient who was in jail. This affects Romaniv’s ability to prescribe controlled substances and signals serious legal trouble starting from late 2025. If you’re connected to his practice or rely on his prescriptions, expect changes and tighter controls soon.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
Previous / Next Documents
Previous: 2025-04750, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a closed virtual meeting on April 30, 2025, to review grant applications focused on small business gynecological health projects. This meeting affects researchers and small businesses seeking funding, ensuring their private information stays safe. No direct money changes are announced, but the grant review could lead to new funding decisions soon.
Next: 2025-04753, William Needham, N.P.; Decision and Order
William Needham, a nurse practitioner from Mississippi, lost his DEA registration because he no longer has the state authority to handle controlled substances. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately, with no money penalties mentioned.